Company intelligence / Profile preview

ingarden

Ownership: Private
Development stage: Commercial

Overview

ingarden has developed an automated mini-garden system for home use that enables consumers to grow fresh, nutrient-rich microgreens in seven days. Their NutriMed™ technology focuses on combating dietary nutrient deficiencies by optimizing the nutritional content of sprouts and vegetables grown at home.

Industry: Food & Nutrition

Partnerships

Gemüsering Stuttgart GmbHfounders of Ankerkautfounders of Invincible BrandsCEO of Kitchen Stories

Beyond the preview

Go deeper on ingarden.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ingarden.

Explore the full profile